89bio, Inc. (NASDAQ:ETNB – Get Free Report) shares reached a new 52-week low on Wednesday . The stock traded as low as $6.96 and last traded at $7.10, with a volume of 74891 shares traded. The stock had previously closed at $7.21. Wall Street Analysts Forecast Growth A number of analysts recently commented on the […]
By Colin Kellaher Akero Therapeutics shares lost two-thirds of their value and fell to a 52-week low on Tuesday after the biotechnology company said a Phase.
By Colin Kellaher 89bio has won U.S. Food and Drug Administration breakthrough-therapy designation for its pegozafermin drug candidate in nonalcoholic.
89bio, Inc. (NASDAQ:ETNB – Get Free Report) shares were up 2.5% during trading on Wednesday . The company traded as high as $17.60 and last traded at $17.56. Approximately 28,726 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 1,519,590 shares. The stock had previously closed at $17.13. […]
Suvretta Capital Management LLC bought a new position in shares of 89bio, Inc. (NASDAQ:ETNB – Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 2,210,536 shares of the company’s stock, valued at approximately $33,666,000. 89bio makes up approximately 1.4% of Suvretta Capital Management […]